mounjaro eli lilly news - Search News

Eli Lilly, Food and Drug Administration

Barron's on MSN · 18h

Eli Lilly’s Weight-Loss Drugs No Longer In Shortage. It’s Bad News for These Stocks.

Eli Lilly’s blockbuster obesity and diabetes drugs Zepbound and Mounjaro are no longer in shortage, according to the Food and Drug Administration.It’s a sign that pharmaceutical firm Lilly is making strides to improve the supply issues that have plagued the sector.

The Wall Street Journal on MSN · 7h

Eli Lilly’s Weight-Loss, Diabetes Drug Shortages Are Over, FDA Says

The removal of Zepbound and Mounjaro from the regulator’s shortage list could lead to restrictions on pharmacies making custom-made versions.

Fast Company · 11h

Hims & Hers Health stock tanks after FDA says competitor Eli Lilly’s weight-loss drug shortage is over

The San Francisco telehealth company had capitalized on the shortage by making copycat versions of popular brand-name GLP-1 medications.

FiercePharma13h

NHS England proposes phased rollout for Eli Lilly's star obesity drug

While Mounjaro was cleared for use in England last year, Lilly put its launch on hold until its pre-filled injection device, ...

1d

Mounjaro and Zepbound no longer in shortage

After nearly two years, federal regulators announced the shortage of the active ingredient in Mounjaro and Zepbound has been ...

18hon MSN

Here’s Why Eli Lilly and Company (LLY) Surged in Q2

PGIM Jennison Health Sciences Fund released its second quarter 2024 investor letter. A copy of the letter can be downloaded ...

13h

Eli Lilly to Invest $4.5B for New Manufacturing & Research Plant

The Medicine Foundry, which is expected to create 400 jobs, will be situated in the LEAP Research and Innovation District in ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results